FR1427100A - Procédé pour l'obtention d'hydroxyflavanne-3-4-diols - Google Patents

Procédé pour l'obtention d'hydroxyflavanne-3-4-diols

Info

Publication number
FR1427100A
FR1427100A FR998508A FR998508A FR1427100A FR 1427100 A FR1427100 A FR 1427100A FR 998508 A FR998508 A FR 998508A FR 998508 A FR998508 A FR 998508A FR 1427100 A FR1427100 A FR 1427100A
Authority
FR
France
Prior art keywords
hydroxyflavanne
diols
obtaining
obtaining hydroxyflavanne
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR998508A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ILE DE RECH PHARMA ET THERAPEU
Original Assignee
ILE DE RECH PHARMA ET THERAPEU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ILE DE RECH PHARMA ET THERAPEU filed Critical ILE DE RECH PHARMA ET THERAPEU
Priority to FR998508A priority Critical patent/FR1427100A/fr
Priority to FR954A priority patent/FR1419521A/fr
Priority to GB51398/65A priority patent/GB1092269A/en
Priority to IL24764A priority patent/IL24764A/en
Priority to US513118A priority patent/US3436407A/en
Priority to DE19651492155 priority patent/DE1492155B/de
Application granted granted Critical
Publication of FR1427100A publication Critical patent/FR1427100A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/32—2,3-Dihydro derivatives, e.g. flavanones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
FR998508A 1964-12-14 1964-12-14 Procédé pour l'obtention d'hydroxyflavanne-3-4-diols Expired FR1427100A (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR998508A FR1427100A (fr) 1964-12-14 1964-12-14 Procédé pour l'obtention d'hydroxyflavanne-3-4-diols
FR954A FR1419521A (fr) 1964-12-14 1965-03-12 Récipient pour solutions injectables par voie parentérale et dispositif obturateur
GB51398/65A GB1092269A (en) 1964-12-14 1965-12-03 Hydroxyflavan 3,4-diols and medicaments based thereon
IL24764A IL24764A (en) 1964-12-14 1965-12-10 Method of producing hydroxy-flavan 3,4-diols
US513118A US3436407A (en) 1964-12-14 1965-12-10 Hydroxyflavin 3,4-diols,a method of producing them and medicament based thereon
DE19651492155 DE1492155B (de) 1964-12-14 1965-12-13 Verfahren zur Extraktion von Hydroxy flavan 3,4 diolen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR998508A FR1427100A (fr) 1964-12-14 1964-12-14 Procédé pour l'obtention d'hydroxyflavanne-3-4-diols
FR9054 1965-03-12

Publications (1)

Publication Number Publication Date
FR1427100A true FR1427100A (fr) 1966-02-04

Family

ID=26162367

Family Applications (2)

Application Number Title Priority Date Filing Date
FR998508A Expired FR1427100A (fr) 1964-12-14 1964-12-14 Procédé pour l'obtention d'hydroxyflavanne-3-4-diols
FR954A Expired FR1419521A (fr) 1964-12-14 1965-03-12 Récipient pour solutions injectables par voie parentérale et dispositif obturateur

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR954A Expired FR1419521A (fr) 1964-12-14 1965-03-12 Récipient pour solutions injectables par voie parentérale et dispositif obturateur

Country Status (4)

Country Link
US (1) US3436407A (fr)
FR (2) FR1427100A (fr)
GB (1) GB1092269A (fr)
IL (1) IL24764A (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092743A1 (en) * 1970-06-15 1972-01-28 Aquitaine Invest Pharma Complete extraction of total flavanol gomers from plats -peripheral - venous activity
FR2643073A1 (fr) * 1989-02-15 1990-08-17 Expansion Rech Phytochimie Procede de preparation d'extraits polyphenoliques de type flavane-3-ol purifies et extraits obtenus
EP0692480A1 (fr) 1994-07-12 1996-01-17 Berkem Procédé de préparation d'extraits contenant des composés polyphénoliques oligomères de type catéchiques à partir de sources végétales et extraits obtenus
FR2725447A1 (fr) * 1994-10-11 1996-04-12 Sanofi Sa Procede d'obtention d'oligomeres procyanidoliques
FR2734478A1 (fr) * 1995-05-23 1996-11-29 Berkem Sa Composition cosmetique ou pharmaceutique utilisable par voie topique ou orale ayant des proprietes antiradicalaires et un pouvoir filtrant vis-a-vis des uv
US5928646A (en) * 1996-05-30 1999-07-27 Berkem Process for extracting catechin polyphenols from potentillas, extract obtained and its use
US6805873B2 (en) 2002-02-26 2004-10-19 Diana Ingredients S.A. Use of a dihydrochalcone-rich phenolic fraction in a cosmetic treatment
US7041322B2 (en) 2001-03-23 2006-05-09 Diana Ingredients S.A. Phloridzin-rich phenolic fraction and use thereof as a cosmetic, dietary or nutraceutical agent

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4510115A (en) * 1982-11-03 1985-04-09 Baxter Travenol Laboratories, Inc. Method for forming layered thermoplastic articles
US4698360B1 (en) * 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
US5719178A (en) * 1995-11-20 1998-02-17 Paul; Julie Chasen Methods and compositions for treating attention-deficit/hyperactivity disorder
JPH09175982A (ja) * 1995-12-28 1997-07-08 Nikka Uisukii Kk 化粧品
GB2349087B (en) * 1996-09-20 2000-12-06 Howard Foundation Improvements in or relating to food supplements
US6238673B1 (en) 1996-09-20 2001-05-29 The Howard Foundation Method of producing high flavonol content polyphenol compositions
US6569446B1 (en) 1996-09-20 2003-05-27 The Howard Foundation Solubilization of flavonols
TR199900626T2 (xx) * 1996-09-20 1999-07-21 The Howard Foundation Flavonol i�eren besinler.
US5817299A (en) * 1996-11-01 1998-10-06 E-L Management Corp. Non-chemical sunscreen composition
US6544581B1 (en) 1999-06-22 2003-04-08 Canandaigua Wine Company, Inc. Process for extraction, purification and enrichment of polyphenolic substances from whole grapes, grape seeds and grape pomace
WO2001011988A2 (fr) * 1999-08-13 2001-02-22 Dry Creek Nutrition, Inc. Nouvelles compositions polymeres polyphenoliques, isolement de ces compositions, et modification et amelioration des qualites organoleptiques de produits comestibles
JPWO2005070443A1 (ja) * 2004-01-21 2007-12-27 株式会社東洋新薬 樹皮抽出物
US20070003644A1 (en) * 2005-04-16 2007-01-04 Unitel Technologies, Inc. Concentrated polyphenolic product and process for making the same
JP2007306872A (ja) * 2006-05-19 2007-11-29 Suntory Ltd プロアントシアニジン含有茶飲料
US9084434B2 (en) 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
US8114445B2 (en) * 2008-11-07 2012-02-14 Reliv International Inc. Dietary supplement for promoting wellness and weight loss and methods of administering the same
US9308230B2 (en) 2009-08-12 2016-04-12 Horphag Research Ip Combination of proanthocyanidins and centella asiatica for the treatment of atherosclerosis
MX2012015059A (es) 2010-06-25 2013-04-03 Horphag Res Ip Pre Ltd Composicion para mejorar el bienestar sexual.
CN108299371A (zh) * 2018-05-07 2018-07-20 黑龙江中医药大学 一种从蓝莓叶提取原花青素的方法
PL4164629T3 (pl) 2020-06-18 2024-11-18 Horphag Research Ip (Pyc) Ltd. Procyjanidyny do leczenia zaburzenia czynności śródbłonka spowodowanego przez COVID-19

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2744919A (en) * 1952-09-09 1956-05-08 Ervin F Kurth Producing pure dihydroquercetin
US2870165A (en) * 1956-06-20 1959-01-20 Rayonier Inc Process for recovering flavonoids from bark
US3131198A (en) * 1961-07-24 1964-04-28 Weyerhaeuser Co Processing of aqueous extracts of bark
US3266903A (en) * 1963-01-25 1966-08-16 Jurd Leonard Methods of using flavylium compounds for food coloring

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092743A1 (en) * 1970-06-15 1972-01-28 Aquitaine Invest Pharma Complete extraction of total flavanol gomers from plats -peripheral - venous activity
FR2643073A1 (fr) * 1989-02-15 1990-08-17 Expansion Rech Phytochimie Procede de preparation d'extraits polyphenoliques de type flavane-3-ol purifies et extraits obtenus
EP0384796A1 (fr) * 1989-02-15 1990-08-29 Societe Civile Pour L' Expansion De La Recherche En Phytochimie Appliquee Procédé de préparation d'extraits polyphénoliques de type flavane-3-ol purifiés et extraits obtenus
EP0692480A1 (fr) 1994-07-12 1996-01-17 Berkem Procédé de préparation d'extraits contenant des composés polyphénoliques oligomères de type catéchiques à partir de sources végétales et extraits obtenus
US5804192A (en) * 1994-10-11 1998-09-08 Sanofi Process for obtaining procyanidol oligomers from plants by extractions
FR2725447A1 (fr) * 1994-10-11 1996-04-12 Sanofi Sa Procede d'obtention d'oligomeres procyanidoliques
EP0707005A1 (fr) 1994-10-11 1996-04-17 Sanofi Procédé d'obtention d'oligomères procyanidoliques
FR2734478A1 (fr) * 1995-05-23 1996-11-29 Berkem Sa Composition cosmetique ou pharmaceutique utilisable par voie topique ou orale ayant des proprietes antiradicalaires et un pouvoir filtrant vis-a-vis des uv
US5928646A (en) * 1996-05-30 1999-07-27 Berkem Process for extracting catechin polyphenols from potentillas, extract obtained and its use
US7041322B2 (en) 2001-03-23 2006-05-09 Diana Ingredients S.A. Phloridzin-rich phenolic fraction and use thereof as a cosmetic, dietary or nutraceutical agent
US7427418B2 (en) 2001-03-23 2008-09-23 Diana Ingredients S.A. Phloridzin-rich phenolic fraction and use thereof as a cosmetic, dietary or nutraceutical agent
US6805873B2 (en) 2002-02-26 2004-10-19 Diana Ingredients S.A. Use of a dihydrochalcone-rich phenolic fraction in a cosmetic treatment
US7285298B2 (en) 2002-02-26 2007-10-23 Diana Ingredients S.A. Use of a dihydrochalcone-rich phenolic fraction in a cosmetic treatment

Also Published As

Publication number Publication date
IL24764A (en) 1970-06-17
GB1092269A (en) 1967-11-22
US3436407A (en) 1969-04-01
FR4482M (fr) 1966-10-03
DE1492155A1 (de) 1969-12-18
FR1419521A (fr) 1965-11-26

Similar Documents

Publication Publication Date Title
FR1419136A (fr) Procédé d'obtention de 2, 4, 6, 8, 9-pentaaza-bicyclo-[3, 3, 1]-nona-2, 6-diènes
FR1451265A (fr) Procédé d'obtention d'alpha-hydroxy-phénylalanines
FR1419542A (fr) Procédé pour l'obtention de matières de revêtement
FR1455727A (fr) Procédé d'obtention de profilés pour le bâtiment
FR1500157A (fr) Procédé d'obtention de lespécapitoside
FR1508423A (fr) Procédé pour l'obtention d'une protéine
FR1451264A (fr) Procédé d'obtention d'alpha-amino-phénylalanines
FR1426132A (fr) Procédé pour l'obtention de thiocarbamato halogéno-alcanes
FR1433370A (fr) Procédé d'obtention de nu1-acétyl p-aminobenzènesulfamides
FR1410252A (fr) Procédé nouveau d'obtention de polymères auto-démoulables
FR1520264A (fr) Procédé pour l'obtention de 11beta-17alpha-hydroxystéroïdes
FR1443108A (fr) Procédé pour l'obtention de bicarbonate d'amino-guanidine
FR1510213A (fr) Procédé pour l'obtention de tétrahydrobenzimidazoles
FR1542073A (fr) Procédé perfectionné pour l'obtention d'aminophénols
FR1402663A (fr) Procédé d'obtention des 5-alcoyl-2-pyrrolidones
CH433388A (fr) Procédé d'obtention du N-cinnamoyl-P-aminophénol
FR1351939A (fr) Procédé pour l'obtention de cyclo-buta-diindène
FR1390344A (fr) Procédé d'obtention de plots pour contacteurs
FR1523166A (fr) Procédé pour l'obtention d'antitoxines
FR1397537A (fr) Procédé pour l'obtention d'alcaloïdes de rauwolfia
FR1447481A (fr) Procédé d'obtention de l'urokinase
FR1368303A (fr) Procédé pour l'obtention de la 1-carbéthoxyméthyl-4-carbéthoxypipéridine
CH415680A (fr) Procédé perfectionné d'obtention d'alpha-thiényl-1-phényl-1-carbinols
FR1482810A (fr) Procédé pour l'obtention d'alkinediols
BE618130Q (fr) Procédé pour l'obtention d'alkinediols